Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity

v3.23.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021   23,665,991    
Beginning balance at Dec. 31, 2021 $ 48,787 $ 237 $ 182,482 $ (133,932)
Issuances of common stock:        
Share-based compensation (in shares)   29,916    
Share-based compensation 899   899  
Warrant and option exercises (cash and cashless) (in shares)   12,211    
Warrant and option exercises (cash and cashless) 3   3  
Net loss for the period (3,959)     (3,959)
Ending balance (in shares) at Mar. 31, 2022   23,708,118    
Ending balance at Mar. 31, 2022 $ 45,730 $ 237 183,384 (137,891)
Beginning balance (in shares) at Dec. 31, 2022 24,578,983 24,578,983    
Beginning balance at Dec. 31, 2022 $ 36,887 $ 246 187,008 (150,367)
Issuances of common stock:        
Share-based compensation (in shares)   3,782    
Share-based compensation 1,307   1,307  
Payments for taxes related to net share settlement of equity awards (in shares)   (514)    
Payments for taxes related to net share settlement of equity awards (5)   (5)  
Net loss for the period $ (5,609)     (5,609)
Ending balance (in shares) at Mar. 31, 2023 24,582,251 24,582,251    
Ending balance at Mar. 31, 2023 $ 32,580 $ 246 $ 188,310 $ (155,976)